Daily as of 3 Nov 16:00 ET
- Price
- below both $2.04 vs 50 $2.78 / 200 $3.26
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 6 Apr 2026 · projected 26 bars out
ALT | AltimmuneNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$2.04
+$0.02 (+0.99%)
Altimmune (ALT) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2020.
The 50 SMA has sat below the 200 on the daily since Apr 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- below both $2.04 vs 50 $3.46 / 200 $5.61
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross week of 24 Jul 2023 · projected 19 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- below both $2.04 vs 50 $2.36 / 200 $2.86
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 14 Oct 2026 · projected 26 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 14 Oct 2026 | 💀Death | 4-hour | 26 bars out | Not tested |
| 26 Aug 2026 | 🟨Golden | 4-hour | 29 bars out | Not tested |
| 6 Apr 2026 | 💀Death moderate | daily | 26 bars out | Not tested |
| 10 Mar 2026 | 💀Death | 4-hour | 21 bars out | Not tested |
| 21 Jan 2026 | 🟨Golden flat | daily | not projected | 1 bar cross test |
About ALT
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$10M
4-hour coverageYes, since Oct 2025
History on recordSince 2020
SectorHealthcare
Cap bandsmall